Cardiovascular Systems, Inc. provided earnings guidance for the year ending June 30, 2023. For the year, the company expects revenue o of $255 million to $265 million and net loss in a range of 9% to 11% of revenues.
Cardiovascular Systems, Inc.
Equities
CSII
US1416191062
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-6.24% | 181B | |
-6.39% | 101B | |
-5.97% | 67.54B | |
-9.61% | 45.09B | |
+8.84% | 44.37B | |
+8.17% | 40.7B | |
+12.69% | 29.85B | |
+10.67% | 24.49B | |
-7.83% | 23.99B |